olanzapine and fluoxetine
Generic: olanzapine and fluoxetine
Labeler: teva pharmaceuticals usa, inc.Drug Facts
Product Profile
Brand Name
olanzapine and fluoxetine
Generic Name
olanzapine and fluoxetine
Labeler
teva pharmaceuticals usa, inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
fluoxetine hydrochloride 25 mg/1, olanzapine 3 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0093-5503
Product ID
0093-5503_49dfc18c-9d68-4489-83f5-d59bb2596b80
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA202074
Listing Expiration
2026-12-31
Marketing Start
2013-04-10
Pharmacologic Class
Established (EPC)
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
00935503
Hyphenated Format
0093-5503
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
olanzapine and fluoxetine (source: ndc)
Generic Name
olanzapine and fluoxetine (source: ndc)
Application Number
ANDA202074 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 25 mg/1
- 3 mg/1
Packaging
- 30 CAPSULE in 1 BOTTLE (0093-5503-56)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "49dfc18c-9d68-4489-83f5-d59bb2596b80", "openfda": {"nui": ["N0000175430"], "upc": ["0300935506562", "0300935503561", "0300935505565", "0300935507569", "0300935504568"], "unii": ["N7U69T4SZR", "I9W7N6B1KJ"], "rxcui": ["403969", "403970", "403971", "403972", "721787"], "spl_set_id": ["3c28cf18-01a3-468a-ab3e-8aa82f918251"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (0093-5503-56)", "package_ndc": "0093-5503-56", "marketing_start_date": "20130410"}], "brand_name": "Olanzapine and Fluoxetine", "product_id": "0093-5503_49dfc18c-9d68-4489-83f5-d59bb2596b80", "dosage_form": "CAPSULE", "pharm_class": ["Atypical Antipsychotic [EPC]", "Serotonin Reuptake Inhibitor [EPC]", "Serotonin Uptake Inhibitors [MoA]"], "product_ndc": "0093-5503", "generic_name": "Olanzapine and Fluoxetine", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Olanzapine and Fluoxetine", "active_ingredients": [{"name": "FLUOXETINE HYDROCHLORIDE", "strength": "25 mg/1"}, {"name": "OLANZAPINE", "strength": "3 mg/1"}], "application_number": "ANDA202074", "marketing_category": "ANDA", "marketing_start_date": "20130410", "listing_expiration_date": "20261231"}